摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-ethyl-2-methyl-3(2H)-furanone | 82782-13-6

中文名称
——
中文别名
——
英文名称
5-ethyl-2-methyl-3(2H)-furanone
英文别名
2-Methyl-5-ethyl-3(2H)-furanone;5-ethyl-2-methylfuran-3-one
5-ethyl-2-methyl-3(2H)-furanone化学式
CAS
82782-13-6
化学式
C7H10O2
mdl
——
分子量
126.155
InChiKey
SKJNEYSTLJSDDX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    9
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    trifluoro-methanesulfonic acid 3-isopropyl-3-methoxy-3a-methyl-4-oxo-6-vinyl-tetrahydro-furo[3,4-c]furan-1-ylmethyl ester 、 5-ethyl-2-methyl-3(2H)-furanone双(三甲基硅烷基)氨基钾 作用下, 以 甲苯 为溶剂, 反应 2.83h, 以38%的产率得到4-(5-ethyl-2-methyl-3-oxo-2,3-dihydro-furan-2-ylmethyl)-6-isopropyl-6-methoxy-6a-methyl-3-vinyl-tetrahydro-furo[3,4-c]furan-1-one
    参考文献:
    名称:
    抗肿瘤倍半萜类(+)-香叶内酯A的不对称全合成和形式全合成。
    摘要:
    [结构:见文字]。报道了一种新的不对称全合成(+)-香叶内酯A,其中使用了Hoveyda-Grubbs闭环复分解(RCM)反应组装了九元氧代宁环,并使3(2H)-之间的烯醇化烷基化。呋喃酮2和O-三氟甲磺酸3用于C(9)-C(10)键结构。埃文斯(Evans)不对称羟醛反应和Sharpless不对称环氧化用于立体选择性地安装目标结构的C(6),C(7)和C(8)立体中心。
    DOI:
    10.1021/ol0700862
  • 作为产物:
    描述:
    1-(3-乙基-1,2-恶唑-5-基)乙酮 在 palladium on activated charcoal sodium tetrahydroborate 、 氢气 作用下, 以 甲醇乙醇 为溶剂, 反应 13.0h, 生成 5-ethyl-2-methyl-3(2H)-furanone
    参考文献:
    名称:
    New 5-(2-ethenylsubstituted)-3(2H)-furanones with in vitro antiproliferative activity
    摘要:
    A convenient route to new 3(2H)-furanones is described through hydrogenolysis and subsequent acidic hydrolysis of isoxazoles. The antiproliferative activity of title compounds were evaluated against leukemia-, carcinoma-, neuroblastoma-, and sarcoma-derived human cell lines in comparison to the natural compound geiparvarin. The structure activity relationship indicated that the maximum in vitro antiproliferative activity correlates with the presence of a heterocyclic ring on the ethenyl moiety. (C) 2003 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4020(03)00776-2
点击查看最新优质反应信息

文献信息

  • Process for the preparation of naphthalen-2-yl-pyrazol-3-one intermediates useful in the synthesis of sigma receptor inhibitors
    申请人:Laboratorios Del. Dr. Esteve, S.A.
    公开号:EP2112139A1
    公开(公告)日:2009-10-28
    The invention relates to a process for preparing naphthalen-2-yl-pyrazol-3-one intermediates, tautomers, and salts thereof, to novel intermediates, and to the use of the intermediates in the preparation of sigma receptor inhibitors.
    这项发明涉及一种制备萘-2-基吡唑-3-酮中间体、互变异构体及其盐的过程,涉及新型中间体,并涉及将这些中间体用于制备σ受体抑制剂。
  • Andersen, Soeren H.; Das, Nalin B.; Joergensen, Ruth D., Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry, 1982, vol. 36, # 1, p. 1 - 14
    作者:Andersen, Soeren H.、Das, Nalin B.、Joergensen, Ruth D.、Kjeldsen, Gunhild、Knudsen, Jes S.、et al.
    DOI:——
    日期:——
  • A total synthesis of (+)-eremantholide A
    作者:Ken-ichi Takao、Hiroshi Ochiai、Takahiko Hashizuka、Hirokazu Koshimura、Kin-ichi Tadano、Seiichiro Ogawa
    DOI:10.1016/0040-4039(95)00066-l
    日期:1995.2
    Stereoselective and enantiospecific total synthesis of (+)-eremantholide A (1) is described. The present total synthesis features 1) regio- and stereoselective radical carbocyclization of D-glurose-derived gamma-lactone 7, and 2) a nine-membered ring formation by the coupling reaction of bicyclic triflate 18 and known furanone 19 followed by a vinylogous aldol reaction.
  • Novel Total Synthesis of (+)-Eremantholide A
    作者:Ken-ichi Takao、Hiroshi Ochiai、Ken-ichi Yoshida、Takahiko Hashizuka、Hirokazu Koshimura、Kin-ichi Tadano、Seiichiro Ogawa
    DOI:10.1021/jo00130a017
    日期:1995.12
    Stereoselective total synthesis of (+)-eremantholide A (1), a cytotoxic furanoheliangolide sesquiterpene, was accomplished in an enantiospecific fashion. The total synthesis featured the following three key synthetic strategies. (1) Intramolecular cyclization of carbon-radicals derived from xanthates 19a or 19b proceeded regio- and stereoselectively in an exclusive 5-exo-dig mode to provide bicyclic lactones 20a or 20b. Further functional group manipulations of 20a and 20b efficiently afforded a highly substituted 3,7-dioxabicyclo[3.3.0]octan-2-one derivative 34, which served as a synthetic equivalent to the A/B ring system in 1. (2) Alkylation of the enolate of 3(2H)-furanone 36 with triflate 35 was thoroughly investigated to maximize formation of the C-alkylated diastereomers, either 10R-isomer 37 or 10S-isomer 38. It was found that choice of the base, solvent, and/or additive was critical to the diastereoselectivity. Furthermore, the 10R-isomer 50 was also prepared in increased yield and improved diastereoselectivity by coupling 36 with A/B ring equivalent 49. (3) In a later stage of the total synthesis, construction of the strained 11-oxabicyclo-[6.2.1]undeca-2,10-dien-9-one system (the C/D ring) was accomplished by means of an intramolecular vinylogous aldol reaction of aldehyde 52, prepared from 10R-isomer 40, followed by base-catalyzed beta-elimination of the corresponding mesylates 54. On the other hand, by employing analogous reaction conditions, the 10S-isomer 56 was transformed into unnatural (-)-10-epi-eremantholide A (61).
  • DIARYL[A, G]QUINOLIZIDINE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USES THEREOF
    申请人:Shanghai Institute of Materia Medica, Chinese Academy of Sciences
    公开号:EP2848617B1
    公开(公告)日:2022-01-12
查看更多

同类化合物

(2R)-4-十六烷酰基-3-羟基-2-(羟甲基)-2H-呋喃-5-酮 马来酸酐-丙烯酸共聚物钠盐 马来酸酐-d2 马来酸酐-13C4 马来酸酐-1-13C 马来酸酐 顺丁烯酸酐-2,3-13C2 顺丁烯二酐与2,2-二甲基-1,3-丙二醇和1,2-丙二醇的聚合物 雄甾-3,5,9(11)-三烯-17-酮,3-甲氧基-(8CI,9CI) 阿西弗兰 阻垢分散剂 重氮基烯,二环[2.2.1]庚-1-基(1,1-二甲基乙基)-,(Z)-(9CI) 赤藻糖酸钠 螺甲螨酯代谢物 M01 葫芦巴内酯 苯基顺酐 聚氧乙烯(2-甲基-2-丙烯基)甲基二醚-马来酸酐共聚物 聚(甲基乙烯基醚-ALT-马来酸酐) 聚(异丁烯-马来酸酐) 聚(乙烯-co-丙烯酸乙酯-co-顺丁烯二酐) 聚(乙烯-co-丙烯酸丁酯-co-马来酸酐) 维生素C钠 维生素C磷酸酯钠 维生素C磷酸酯 维生素C杂质 维生素C亚铁盐 维生素C乙基醚 维生素 C 维他命C磷酸镁盐 纯绿青霉酸 粘氯酸酐 粘氯酸酐 粘氯酸酐 粘康酸内酯 粉青霉酸酐 穿心莲丁素 硫酰胺,(3-氰基-5,6,7,8-四氢-4H-环庚三烯并[b]噻吩并-2-基)-(9CI) 白头翁素 甲基7-氧杂双环[2.2.1]庚-2,5-二烯-2-羧酸酯 甲基5-甲基-4,5-二氢-3-呋喃羧酸酯 甲基4-氰基-2,5-二氢-3-呋喃羧酸酯 甲基4,5-二氢-2-呋喃羧酸酯 甲基3-甲基-2,3-二氢-3-呋喃羧酸酯 甲基2-甲基-5-亚甲基-4,5-二氢-3-呋喃羧酸酯 甲基2-甲基-2,5-二氢-2-呋喃羧酸酯 甲基2-氨基-4,5-二氢-3-呋喃羧酸酯 甲基2-乙烯基-4,5-二氢-3-呋喃羧酸酯 特春酸 溴代马来酸酐 氟2-(5-氧代-2H-呋喃-2-基)乙酸酯